FDA guidance seeks to better integrate patient priorities into drug development

Patient-centered drug development must start with an understanding of what patients feel is important about their condition and the attributes they’d like to see in medicines. A draft guidance FDA released Monday on Methods to Identify What is Important to Patients provides a road map for patients, drug developers and others to gather information about patients’ priorities.

The draft guidance outlines research methods and provides recommendations on collecting data from populations such as children and the cognitively impaired that can be difficult to survey using traditional techniques that rely on surveys or interviews. ...